P3 Trademark

Trademark Overview

On Wednesday, July 2, 2008, a trademark application was filed for P3 with the United States Patent and Trademark Office. The USPTO has given the P3 trademark a serial number of 77513523. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, November 14, 2022. This trademark is owned by Covance Inc.. The P3 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

conducting clinical trials of drugs and biological products
p3

General Information

Serial Number77513523
Word MarkP3
Filing DateWednesday, July 2, 2008
Status710 - CANCELLED - SECTION 8
Status DateMonday, November 14, 2022
Registration Number3660127
Registration DateTuesday, July 28, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2009

Trademark Statements

Pseudo MarkP THREE
Goods and Servicesconducting clinical trials of drugs and biological products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, November 14, 2022
Primary Code042
First Use Anywhere DateTuesday, February 28, 2006
First Use In Commerce DateTuesday, February 28, 2006

Trademark Owner History

Party NameLABCORP DRUG DEVELOPMENT INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 085406233
Party NameCovance Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233
Party NameCovance Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233
Party NameCovance Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233

Trademark Events

Event DateEvent Description
Tuesday, November 15, 2022NOTICE OF CANCELLATION SEC. 8 EMAILED
Monday, November 14, 2022CANCELLED SEC. 8 (10-YR)
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 26, 2022POST REGISTRATION ACTION MAILED - SEC. 8
Friday, April 8, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, October 8, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Monday, September 21, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sunday, March 22, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, March 20, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 23, 2020TEAS SECTION 8 & 9 RECEIVED
Thursday, September 20, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 20, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 28, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 13, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 13, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, August 12, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 15, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 28, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, May 12, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2009NOTICE OF PUBLICATION
Wednesday, April 8, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 8, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 8, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 7, 2009ASSIGNED TO LIE
Monday, April 6, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 7, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 7, 2008NON-FINAL ACTION E-MAILED
Tuesday, October 7, 2008NON-FINAL ACTION WRITTEN
Tuesday, October 7, 2008ASSIGNED TO EXAMINER
Tuesday, July 8, 2008NOTICE OF PSEUDO MARK MAILED
Monday, July 7, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

biological products drugs trials clinical conducting